CIK 0001676725
- Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474268251
- Phone
- +1 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale SVP, Chief Scientific Officer sold 1,500 shares at $20.22 ($30,333)
- 4 Open-market sale SVP, Chief Scientific Officer sold 5,000 shares at $20.22 ($101,093)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP, Chief Scientific Officer sold 5,000 shares at $20.74 ($103,697)
- 4 Open-market sale SVP, Head of Biology sold 2,000 shares at an average $21.03 ($42,052)
- 4 Open-market sale See Explanation of Responses sold 46,409 shares at $18.00 ($835,362)
- 4 Open-market sale SVP, Head of Biology sold 2,501 shares at an average $18.46 ($46,158)
- 4 Option exercise President and CEO acquired 8,000 shares (option exercise)
- 4 Option exercise SVP, Chief Scientific Officer acquired 7,750 shares (option exercise)
- 4 Other acquisition SVP, Chief Financial Officer acquired 444 shares (other)
- 4 Open-market sale SVP, General Counsel sold 1,979 shares at an average $15.37 ($30,410)
- 4 Open-market sale 10% owner sold 800,000 shares at $13.66 ($10,928,000)
- 4 Open-market buy 10% owner bought 2,531 shares at $13.32 ($33,704)
Page 7 of 10 · 197 filings